Jaguar Health Inc. (JAGX)
Jaguar Health Statistics
Share Statistics
Jaguar Health has 11.80M shares outstanding. The number of shares has increased by -94.29% in one year.
| Shares Outstanding | 11.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 27.67% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.30M |
| Failed to Deliver (FTD) Shares | 883 |
| FTD / Avg. Volume | 0.2% |
Short Selling Information
The latest short interest is 332.32K, so 2.82% of the outstanding shares have been sold short.
| Short Interest | 332.32K |
| Short % of Shares Out | 2.82% |
| Short % of Float | 3.23% |
| Short Ratio (days to cover) | 1.12 |
Valuation Ratios
The PE ratio is -0.08 and the forward PE ratio is -0.42.
| PE Ratio | -0.08 |
| Forward PE | -0.42 |
| PS Ratio | 0.36 |
| Forward PS | 0.5 |
| PB Ratio | 0.7 |
| P/FCF Ratio | -0.11 |
| PEG Ratio | n/a |
Enterprise Valuation
Jaguar Health Inc. has an Enterprise Value (EV) of 34.12M.
| EV / Earnings | -0.83 |
| EV / Sales | 3.5 |
| EV / EBITDA | -1.03 |
| EV / EBIT | -0.99 |
| EV / FCF | -1.03 |
Financial Position
The company has a current ratio of 2, with a Debt / Equity ratio of 7.48.
| Current Ratio | 2 |
| Quick Ratio | 1.34 |
| Debt / Equity | 7.48 |
| Total Debt / Capitalization | 88.2 |
| Cash Flow / Debt | -0.9 |
| Interest Coverage | -5.37 |
Financial Efficiency
Return on equity (ROE) is -8.32% and return on capital (ROIC) is -81.66%.
| Return on Equity (ROE) | -8.32% |
| Return on Assets (ROA) | -0.81% |
| Return on Capital (ROIC) | -81.66% |
| Revenue Per Employee | 199.20K |
| Profits Per Employee | -842.86K |
| Employee Count | 49 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 0.22 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -86.02% in the last 52 weeks. The beta is 0.88, so Jaguar Health 's price volatility has been higher than the market average.
| Beta | 0.88 |
| 52-Week Price Change | -86.02% |
| 50-Day Moving Average | 1 |
| 200-Day Moving Average | 3.56 |
| Relative Strength Index (RSI) | 39.13 |
| Average Volume (20 Days) | 435.10K |
Income Statement
In the last 12 months, Jaguar Health had revenue of 9.76M and earned -41.30M in profits. Earnings per share was -107.42.
| Revenue | 9.76M |
| Gross Profit | 7.72M |
| Operating Income | -34.29M |
| Net Income | -41.30M |
| EBITDA | -33.13M |
| EBIT | -34.29M |
| Earnings Per Share (EPS) | -107.42 |
Balance Sheet
The company has 6.47M in cash and 37.09M in debt, giving a net cash position of -30.63M.
| Cash & Cash Equivalents | 6.47M |
| Total Debt | 37.09M |
| Net Cash | -30.63M |
| Retained Earnings | -308.25M |
| Total Assets | 58.47M |
| Working Capital | 16.77M |
Cash Flow
In the last 12 months, operating cash flow was -33.24M and capital expenditures 0, giving a free cash flow of -33.24M.
| Operating Cash Flow | -33.24M |
| Capital Expenditures | 0 |
| Free Cash Flow | -33.24M |
| FCF Per Share | -86.46 |
Margins
Gross margin is 79.13%, with operating and profit margins of -351.31% and -423.11%.
| Gross Margin | 79.13% |
| Operating Margin | -351.31% |
| Pretax Margin | -429.27% |
| Profit Margin | -423.11% |
| EBITDA Margin | -339.42% |
| EBIT Margin | -351.31% |
| FCF Margin | -340.56% |
Dividends & Yields
JAGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -12637.65% |
| FCF Yield | -331.08% |
Analyst Forecast
Currently there are no analyst rating for JAGX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on May 23, 2024. It was a backward split with a ratio of 1:60.
| Last Split Date | May 23, 2024 |
| Split Type | backward |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | -9.22 |
| Piotroski F-Score | 5 |